Cell proliferation enhancement

"Cell proliferation enhancement" is not the name of a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to the general biological process by which cells grow and divide to produce two daughter cells, leading to an increase in cell number. This process is fundamental for tissue growth during development, regeneration after injury, and also plays a central role in cancer when dysregulated. The molecular regulation of cell proliferation involves numerous signaling pathways—most notably those triggered by growth factors—which activate intracellular cascades that drive entry into the cell cycle and promote both cellular growth (increase in mass) and division (mitosis)[1][2][4]. Key molecular players include cyclins, cyclin-dependent kinases (CDKs), transcription factors such as E2F family members, tumor suppressors like retinoblastoma protein (Rb), p53 pathway components, among many others[1][3]. Because "cell proliferation enhancement" describes an outcome or effect rather than a discrete druggable entity or protein target classifiable as receptor/enzyme/transporter/etc., it should not be considered a valid therapeutic target name. In summary: > "Cell proliferation enhancement" does **not** refer to any single molecule or receptor but rather describes an increase in the rate of cell division—a complex biological phenomenon regulated by many different proteins and pathways. It cannot be mapped directly onto structured fields for canonical drug targets.[1][2]

Other names

Cell proliferationProliferation enhancementCell growth and division